What's New for the Care-Based Incentive Program
What's New for CBI 2022
New Programmatic Measures
Quality of Care Measures
- Breast Cancer Screening: This measure has been moved from an exploratory to programmatic measure. Measure performance is based on the percentage of women 50–74 years of age who had a mammogram to screen for breast cancer in the past two years.
- Screening for Depression and Follow-Up Plan: This measure has replaced the Antidepressant Medication Management measure. Measure performance is based on the percentage of members 18 to 64 years of age who are screened for depression on the date of the visit using an age-appropriate standardized depression screening tool, and if positive, a follow-up plan is documented on the date of the positive screen.
- Plan All-Cause Readmission points have been redistributed to the Post-Discharge Care
- Points from Ambulatory Care Sensitive Conditions thiab Preventable Emergency Visits have been reallocated to the Quality of Care Measures.
- The Joint Commission (TJC) PCMH certification has been removed from the Behavioral Health Integration FFS measure as a standalone qualification.
New Exploratory Measures
These measures will not qualify for payment in 2022 but are being considered to be added as a paid measure in the 2023 CBI Program.
- Adverse Childhood Experiences (ACEs) in Children and Adolescents: Performance is based on the percentage of members ages 1-21 years of age who are screened for Adverse Childhood Experiences (ACEs) annually using a standardized screening tool.
- Health Plan Health Disparity: This measure will look at health plan performance using the HEDIS Child and Adolescent Well-Care Visit to determine whether different ethnic groups had or did not have equal access to primary care, relative to our largest member population.
- Antidepressant Medication Management
- Maternity Care: Postpartum
- Maternity Care: Prenatal